<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: S12 Nonclinical Biodistribution Considerations for Gene Therapy Products; International Council for Harmonisation; Draft Guidance for Industry; Availability</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: S12 Nonclinical Biodistribution Considerations for Gene Therapy Products; International Council for Harmonisation; Draft Guidance for Industry; Availability</h1>
    <p class="timestamp">Published: 2021-09-09 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled "S12 Nonclinical Biodistribution Considerations for Gene Therapy Products." The draft guidance was prepared under the auspices of the International Council for Harmonisation (ICH), formerly the International Conference on Harmonisation. The draft guidance provides harmonized recommendations for the conduct and overall design of nonclinical biodistribution (BD) studies for gen...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2021-19410</p>
    <p><strong>Publication Date:</strong> 2021-09-09</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2021/09/09/2021-19410/s12-nonclinical-biodistribution-considerations-for-gene-therapy-products-international-council-for">https://www.federalregister.gov/documents/2021/09/09/2021-19410/s12-nonclinical-biodistribution-considerations-for-gene-therapy-products-international-council-for</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2021-19410</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
